These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 2154819

  • 1. [3H] beta-funaltrexamine ([3H] beta-FNA) binds irreversibly to mu opioid receptors in the rat brain: autoradiographic study.
    Liu-Chen LY, Li SX, Rohrbach KW, Lewis ME.
    Prog Clin Biol Res; 1990; 328():61-4. PubMed ID: 2154819
    [No Abstract] [Full Text] [Related]

  • 2. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW, Liu-Chen LY.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [Abstract] [Full Text] [Related]

  • 3. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY, Yang HH, Li S, Adams JU.
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [Abstract] [Full Text] [Related]

  • 4. Autoradiographic study of irreversible binding of [3H]beta-funaltrexamine to opioid receptors in the rat forebrain: comparison with mu and delta receptor distribution.
    Liu-Chen LY, Li SX, Lewis ME.
    Brain Res; 1991 Mar 29; 544(2):235-42. PubMed ID: 1645609
    [Abstract] [Full Text] [Related]

  • 5. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
    Rothman RB, Long JB, Bykov V, Jacobson AE, Rice KC, Holaday JW.
    J Pharmacol Exp Ther; 1988 Nov 29; 247(2):405-16. PubMed ID: 2846819
    [Abstract] [Full Text] [Related]

  • 6. Effects of intracerebroventricular administration of beta-funaltrexamine on [3H]DAMGO binding to rat brain sections.
    Martin TJ, Dworkin SI, Smith JE.
    J Pharmacol Exp Ther; 1993 Oct 29; 267(1):506-14. PubMed ID: 8229781
    [Abstract] [Full Text] [Related]

  • 7. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
    Rothman RB, Bykov V, Mahboubi A, Long JB, Jiang Q, Porreca F, de Costa BR, Jacobson AE, Rice KC, Holaday JW.
    Synapse; 1991 Jun 29; 8(2):86-99. PubMed ID: 1652797
    [Abstract] [Full Text] [Related]

  • 8. Autoradiographic localization of opioid receptor types in the rat small intestine.
    Dashwood MR, Sykes RM, Thompson CS.
    NIDA Res Monogr; 1986 Jun 29; 75():315-8. PubMed ID: 2828980
    [Abstract] [Full Text] [Related]

  • 9. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
    Liu-Chen LY, Li SX, Wheeler-Aceto H, Cowan A.
    Eur J Pharmacol; 1991 Oct 15; 203(2):195-202. PubMed ID: 1666046
    [Abstract] [Full Text] [Related]

  • 10. Alkylation of mu opioid receptors by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats.
    Martin TJ, Dworkin SI, Smith JE.
    J Pharmacol Exp Ther; 1995 Mar 15; 272(3):1135-40. PubMed ID: 7891326
    [Abstract] [Full Text] [Related]

  • 11. Mu/delta opioid site selectivity of some antidepressants.
    Codd EE, Walker RF.
    NIDA Res Monogr; 1986 Mar 15; 75():351-4. PubMed ID: 2828984
    [Abstract] [Full Text] [Related]

  • 12. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW, Holtzman SG.
    J Pharmacol Exp Ther; 1986 Sep 15; 238(3):990-6. PubMed ID: 3018230
    [Abstract] [Full Text] [Related]

  • 13. Comparison of [125I]beta-endorphin binding to rat brain and NG108-15 cells using a monoclonal antibody directed against the opioid receptor.
    Bidlack JM, O'Malley WE, Schulz R.
    Mol Pharmacol; 1988 Feb 15; 33(2):170-7. PubMed ID: 2828912
    [Abstract] [Full Text] [Related]

  • 14. Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections.
    Martin TJ, Sim LJ, Selley DE, deMontis MG, Childers SR.
    Synapse; 1997 Nov 15; 27(3):177-82. PubMed ID: 9329153
    [Abstract] [Full Text] [Related]

  • 15. Binding characteristics of [D-Ala2-MePhe4-Glyol5] enkephalin and [D-Pen2,D-Pen5] enkephalin in rat brain: inhibition studies with fentanyl-like drugs.
    Yeadon M, Kitchen I.
    NIDA Res Monogr; 1986 Nov 15; 75():64-6. PubMed ID: 2829008
    [Abstract] [Full Text] [Related]

  • 16. Stress prevents the chronic ethanol-induced delta opiod receptor supersensitivity in the rat brain.
    Przewłocka B, Lasoń W.
    Pol J Pharmacol Pharm; 1990 Nov 15; 42(2):137-42. PubMed ID: 2177189
    [Abstract] [Full Text] [Related]

  • 17. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
    Morris BJ, Millan MJ, Herz A.
    J Pharmacol Exp Ther; 1988 Nov 15; 247(2):729-36. PubMed ID: 2846828
    [Abstract] [Full Text] [Related]

  • 18. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW, Holtzman SG.
    J Pharmacol Exp Ther; 1986 Sep 15; 238(3):997-1003. PubMed ID: 3018231
    [Abstract] [Full Text] [Related]

  • 19. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R, Auerbach SB.
    J Pharmacol Exp Ther; 2002 Nov 15; 303(2):549-56. PubMed ID: 12388635
    [Abstract] [Full Text] [Related]

  • 20. Light microscopic autoradiographic localization of delta opioid receptors in the rat brain using a highly selective bis-penicillamine cyclic enkephalin analog.
    Gulya K, Gehlert DR, Wamsley JK, Mosberg H, Hruby VJ, Yamamura HI.
    J Pharmacol Exp Ther; 1986 Aug 15; 238(2):720-6. PubMed ID: 3016247
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.